1-3 of 3
Camille Villesuzanne
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Elranatamab real-world step-up dosing patterns in relapsed-refractory multiple myeloma patients: Interim analysis Results of the AMbreLA study

Free
Laurent Frenzel, Thomas Chalopin, Mohamad Mohty, Cyrille Touzeau, Caroline Jacquet, Andrea Pieragostini, Manon Sapet, Camille Villesuzanne, Deborah Assouan, Lydia Montes, Daniel Re, Olivier Allangba, Julie Gay, Murielle Roussel, Yong Chen, Guido Nador, Yves Brault, Sikha Dabo, Karen Gogat-Marchant, Elodie Priol, Pierre-Alexandre Squara, Aurore Perrot
Journal: Blood
Blood (2025) 146 (Supplement 1): 8151.
https://doi.org/10.1182/blood-2025-8151
Published: 2025
Journal Articles

Carfil-HAD Pilote Study: Secure Outsourcing in Hospitalization at Home (HAH) of Carfilzomib in the Treatment of Multiple Myeloma and Validation of the Organization of the Care Model for Short-Duration Intravenous Chemotherapy at Home

Free
Mohamed Touati, Camille Villesuzanne, Gaelle Maillan, Natalia Dmytruk, Caroline Streitcher, Catherine Brillat, Frederica Bompart, Chantal Tisseuil, Sophie Sardin, Stephane Girault, Ludovic Lamarsalle, Murielle Roussel, Stéphane Moreau
Journal: Blood
Blood (2024) 144 (Supplement 1): 7615.
https://doi.org/10.1182/blood-2024-208409
Published: 2024
Journal Articles

Overview of the French Practice: Therapeutic Strategies in Patient's First Relapse or Refractory Non IgM AL Amyloidosis

Free
Camille Villesuzanne, Stephanie Harel, Alexis Talbot, MD, Bruno Royer, MD, Naelle Lombion, Fabien Lebras, MD, Mathilde Nouvier, MD, Arnaud Jaccard, MD PhD, Bertrand Arnulf
Journal: Blood
Blood (2018) 132 (Supplement 1): 3297.
https://doi.org/10.1182/blood-2018-99-114834
Published: 2018